Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9889 - 9896 of 12015 results
EEOC's Attempt to Limit Reach of Severance Agreements Hits Roadblock… Again
December 16, 2014| Blog| Viewpoint
Supreme Court Finds that Post-Shift Employee Security Screenings Noncompensable Activity Under the Fair Labor Standards Act
December 16, 2014| Blog| Viewpoint
On the Sixth Day of Privacy, the hackers gave to Sony......
December 16, 2014| Blog| Viewpoint
Back at it Again: NLRB Invalidates Employer’s “Overbroad” Solicitation Rule
December 15, 2014| Blog| Viewpoint
Staffing Companies Hit with Class Action Alleging Violation of Fair Credit Reporting Act
December 15, 2014| Blog| Viewpoint
For the First Time PTAB Upholds Validity of Pharma Patents
December 15, 2014| Blog| Viewpoint
Vermont Doubles Down: Representative Testifies Before Congress Against Federal GMO Labeling Bill
December 15, 2014| Blog| Viewpoint
FTC Centennial: How Health Care Antitrust Has Evolved
December 15, 2014| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|